FDAnews
www.fdanews.com/articles/195404-polyganics-nabs-ce-mark-for-dural-sealant-patch
Grey Approved Stamp

Polyganics Nabs CE Mark for Dural Sealant Patch

January 7, 2020

Polyganics has obtained the CE Mark for its Liqoseal dural sealant patch, a device cleared for use in dural closure, a routine surgical step in neurosurgery.

The device is used as an adjunct to standard dural closure methods, including suturing, to create a watertight closure that prevents cerebrospinal fluid leakage.

The sealant patch’s approval was based on trial data that showed no leakages, clinically significant swellings or device-related adverse events in three-month follow-up results.

View today's stories